Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood

New England Journal of Medicine

Volumn 322, Issue 23, 1990, Pages 1617-1621

  Vichinsky, Elliott P ^a   Earles, Ann ^a   Johnson, Robert A ^c   Hoag, M Silvija ^d   Williams, Amber ^d   Lubin, Bertram ^b  

^a The Department of Hematology/Oncology ^*  (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c Alta Bates Hospital   (United States)

^d Alameda Highland Hospital Campus   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ERYTHROCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOIMMUNIZATION; ANEMIA; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CHILD; CONTROLLED STUDY; ETHNIC OR RACIAL ASPECTS; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

ADOLESCENT; ADULT; ANEMIA; ANEMIA, SICKLE CELL; ANTIBODY FORMATION; BLOOD DONORS; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; COMPARATIVE STUDY; HUMAN; INFANT; ISOANTIBODIES; PHENOTYPE; PROSPECTIVE STUDIES; RACIAL STOCKS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025372673     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199006073222301     Document Type: Article

References (42)

1. Davies SC, Luce PJ, Win AA, Riordan JF, Brozovic M. Acute chest syndrome in sickle-cell disease. Lancet 1984; 1: 36–8.
2. Janik J, Seeler RA. Perioperative management of children with sickle hemoglobinopathy. J Pediatr Surg 1980; 15: 117–20.
3. Lanzkowsky P, Shende A, Karayalcin G, Kim YJ, Aballi AJ. Partial exchange transfusion in sickle cell anemia: use in children with serious complications. Am J Dis Child 1978; 132: 1206–8.
4. Milner PF. Chronic transfusion regimens in sickle cell disease. In: Scott RB, ed. Advances in the pathophysiology, diagnosis, and treatment of sickle cell disease. Vol. 98 of Progress in clinical and biological research. New York: Alan R. Liss, 1982:97–107.
5. Morrison JC, Schneider JM, Whybrew WD, Bucovaz ET, Menzel DM. Prophylactic transfusions in pregnant patients with sickle hemoglobinopathies: benefit versus risk. Obstet Gynecol 1980; 56: 274–80.
6. Morrison JC, Wiser WL. The use of prophylactic partial exchange transfusion in pregnancies associated with sickle cell hemoglobinopathies. Obstet Gynecol 1976; 48: 516–20.
7. Patten E, Patel S, Soto B, Gayle R. Transfusion management of patients with sickle cell disease: sickle cell disease. Ann N Y Acad Sci 1989; 565: 446–8.
8. Piomelli S. Chronic transfusions in patients with sickle cell disease: indications and problems. Am J Pediatr Hematol Oncol 1985; 7: 51–5.
9. Rifkind S, Waisman J, Thompson R, Goldfinger D. RBC exchange pheresis for priapism in sickle cell disease. JAMA 1979; 242: 2317–8.
10. Russell MO, Goldberg HI, Reis L, et al. Transfusion therapy for cerebroascular abnormalities in sickle cell disease. J Pediatr 1976; 88: 382–7.
11. Schmalzer E, Chien S, Brown A. Transfusion therapy in sickle cell disease. Am J Pediatr Hematol Oncol 1982; 4: 395–406.
12. Seeler RA. Intensive transfusion therapy for priapism in boys with sickle cell anemia. J Urol 1973; 110: 360–3.
13. Samaik S, Schomack JL, Lusher JM. The incidence of development of irregular red cell antibodies in patients with sickle cell anemia. Transfusion 1986; 26: 249–52.
14. Orlina AR, Unger PJ, Koshy M. Post-transfusion alloimmunization in patients with sickle cell disease. Am J Hematol 1978; 5: 101–6.
15. Chaplin H Jr, Cassell M. The occasional fallibility of in vitro compatibility tests. Transfusion 1962; 2: 375–84.
16. Brumfield CG, Huddleston JF, DuBois LB, Harris BA Jr. A delayed hemolytic transfusion reaction after partial exchange transfusion for sickle cell disease in pregnancy: a case report and review of the literature. Obstet Gynecol 1984; 63: 13S–15S.
17. Chaplin H Jr, Zarkowsky HS. Combined sickle cell disease and autoimmune hemolytic anemia. Arch Intern Med 1981; 141: 1091–3.
18. Cox JV, Steane E, Cunningham G, Frenkel EP. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988; 148: 2485–9.
19. Davies SC, McWilliam achéal, Hewitt PE, Devenish A, Brozovic M. Red cell alloimmunization in sickle cell disease. Br J Haematol 1986; 63: 241–5.
20. Diamond WJ, Brown FL Jr, Bitterman P, Klein HG, Davey RJ, Winslow RM. Delayed hemolytic transfusion reaction presenting as sickle cell crisis. Ann Intem Med 1980; 93: 231–4.
21. Patten E, Patel S, Soto B, Gayle R. Prevalence of certain clinically significant alloantibodies in sickle cell disease patients: sickle cell disease. Ann N Y Acad Sci 1989; 565: 443–5.
22. Wang WC, Herrad H, Presbury G, Wilimas J. Lymphocyte phenotype and function in chronically transfused children with sickle cell disease. Am J Hematol 1985; 20: 31–40.
23. Milner PF, Squires JE, Larison PJ, Charles WT, Krauss JS. Posttransfusion crises in sickle cell anemia: role of delayed hemolytic reactions to transfusions. South Med J 1985; 78: 1462–9.
24. Ambruso DR, Githens JH, Alcorn R, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion 1987; 27: 94–8.
25. Coles SM, Klein HG, Holland PV. Alloimmunization in two multitransfused patient populations. Transfusion 1981; 21: 462–6.
26. Blumberg N, Ross K, Avila E, Peck K. Should chronic transfusion be matched for antigens other than ABO and Rho(D)? Vox Sang 1984; 47: 205.
27. Luban NLC. Variability in rates of alloimmunization in different groups of children with sickle cell disease: effect of ethnic background. Am J Pediatr Hematol Oncol 1989; 11: 314–9.
28. Rosse WF, Gallagher D, Altman N, et al. Alloimmunization to red blood cell antigens in patients with sickle cell disease. Blood 1985; Suppl 1: 65A. abstract.
29. Alarif L, Castro O, Ofosu M, Dunston G, Scott RB. HLA–B35 is associated with red cell alloimmunization in sickle cell disease. Clin Immunol Immunopathol 1986; 38: 178–83.
30. Giblett ER. A critique of the theoretical hazard of inter- vs. intra-racial transfusion. Transfusion 1961; 1: 233–8.
31. Morton JI, Siegel BV. Stimulation of the reticuloendothelial system and autoimmunity. Adv Exp Med Biol 1979; 121B: 307–15.
32. Mourant A, Kopec A, Domaniewski-Sobczak K. The distribution of human blood groups and other polymorphisms. 2nd ed. London: Oxford University Press, 1976.
33. Ofosu MD, Saunders DA, Dunston GM, Castro O, Alarif L. Association of HLA and autoantibody transfused sickle cell disease patients. Am J Hematol 1986; 22: 27–33.
34. Widmann FK, ed. Technical manual of the American Association of Blood Banks. 8th ed. Philadelphia: J.B. Lippincott, 1981.
35. Hewitt PE, Maclntyre EA, Devenish A, Bowcock SJ, Contreras M. A prospective study of the incidence of delayed haemolytic transfusion reactions following peri-operative blood transfusion. Br J Haematol 1988; 69: 541–4.
36. Moore SB, Taswell HF, Pineda AA, Sonnenberg CL. Delayed hemolytic transfusion reactions: evidence of the need for an improved pretransfusion compatibility test. Am J Clin Pathol 1980; 74: 94–7.
37. Economidou J, Constantoulakis M, Augoustaki O, Adinolfi M. Frequency of antibodies to various antigenic determinants in polytransfused patients with homozygous thalassaemia in Greece. Vox Sang 1971; 20: 252–8.
38. Michail-Merianou V, Pamphili-Panouspoulou L, Piperi-Lowes L, Pelegrinis E, Karaklis A. Alloimmunization to red cell antigens in thalassemia: comparative study of usual versus better-match transfusion programmes. Vox Sang 1987; 52: 95–102.
39. Sirchia G, Zanella A, Parravicini A, Morelati F, Rebulla P, Masera G. Red cell alloantibodies in thalassemia major: results of an Italian cooperative study. Transfusion 1985; 25: 110–2.
40. Kim HC, Bamsley W, Sweisfurth AW. Incidence of alloimmunization in multiply transfused pediatric patients. Transfusion 1984; 24: 417. abstract.
41. Mallory D, Malamut D, Ginther A. Rare blood for patients with sickle cell anemia: sickle cell disease. Ann N Y Acad Sci 1989; 565: 432–3.
42. Beattie KM, Shafer AW. Broadening the base of a rare donor program by targeting minority populations. Transfusion 1986; 26: 401–4.